合生元补充对重症成人患者肠内喂养耐受性、蛋白质稳态和肌肉消耗的影响:一项随机对照试验
该研究将42例需肠内营养的重症成人患者前瞻性随机分为合生元组和安慰剂组(每组21例),干预最长14天。合生元组在入住ICU前4天肠内喂养量、能量和蛋白质摄入较第1天增加,但第14天两组能量和蛋白质稳态及肌肉量维持无统计学显著差异。
要点
- 合生元组第4天肠内喂养量、能量和蛋白质摄入均较第1天显著增加(p<0.05)。
- 第14天氮平衡两组间无统计学显著差异(p=0.41)。
- 合生元组中臂围、24小时尿肌酐及肌酐身高指数基本稳定,安慰剂组下降。
核心结论
- 合生元补充的肠内营养对重症患者第14天的能量和蛋白质稳态及肌肉量维持无统计学显著影响,但可在入住ICU前4天增加肠内喂养量及能量和蛋白质摄入。
研究设计与样本
- 前瞻性随机对照试验,连续纳入42例入住Edalatian Medical ICU且需肠内营养的重症成人患者,合生元组与安慰剂组各21例,干预最长14天。
主要发现
- 合生元组第4天每日平均肠内喂养量为962.5 ± 533.82 ml、能量770 ± 427.05 kcal、蛋白质38.5 ± 21.35 g,第1天分别为590 ± 321.1 ml、472 ± 256.81 kcal、23.6 ± 12.84 g(p < 0.05);安慰剂组变化无统计学显著性。
- 第1天氮平衡合生元组为- 19.84 ± 8.03,安慰剂组为- 10.99 ± 9.12(p = 0.003);第14天合生元组为- 14.18 ± 13.05,安慰剂组为- 9.59 ± 7.71(p = 0.41)。
- 合生元组中臂围、24小时尿肌酐和肌酐身高指数基本稳定,而安慰剂组下降。
临床怎么用
- 作者认为,合生元补充的肠内营养对重症患者第14天的能量和蛋白质稳态及肌肉量维持无统计学显著影响,但可在入住ICU前4天增加肠内喂养量及能量和蛋白质摄入。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Enteral feeding intolerance, energy-protein malnutrition, and muscle wasting are common conditions in the critical care setting. The primary aim of this study was to investigate the effect of synbiotic supplementation on enteral feed volume, energy and protein homeostasis, and muscle mass maintenance in critically ill adult patients. METHODS: A consecutive of 42 patients admitted to the Edalatian Medical ICU, requiring enteral nutrition (EN), were prospectively randomized to receive the synbiotic capsule (containing a combination of Lactobacillus, Bifidobacterium, Streptococcus, and fructooligosaccharides) or placebo (21 patients in each group) for a maximum of 14 days. Enteral intolerance and energy homeostasis were evaluated on a daily basis. Nitrogen balance and 24-h urine creatinine excretion were recorded on days 1 and 14. Mid-arm circumference was recorded every 3 days. RESULTS: Mean EN volume, energy, and protein intake per day were 962.5 ± 533.82 ml, 770 ± 427.05 kcal, and 38.5 ± 21.35 g (fourth day) vs. 590 ± 321.1 ml, 472 ± 256.81 kcal, and 23.6 ± 12.84 g (first day) in the synbiotic group (p < 0.05). Changes in the placebo group were not statistically significant. On day 1, nitrogen balance (NB) was - 19.84 ± 8.03 in the synbiotic vs. - 10.99 ± 9.12 in the placebo group (p = 0.003). On day 14, NB was - 14.18 ± 13.05 in the synbiotic and - 9.59 ± 7.71 in the placebo group (p = 0.41). Mid-arm circumference (MAC), 24-h urine creatinine, and creatinine-height index were almost steady in the synbiotic group, while they decreased in the placebo group. CONCLUSION: Overall, it can be concluded that enteral nutrition supplemented with synbiotics has no statistically significant effect on energy and protein homeostasis and muscle mass maintenance of critically ill patients on day 14, but it can increase enteral feed volume and energy and protein intake during the first 4 days of ICU admission. TRIAL REGISTRATION: The trial protocol has been approved in Iranian Registry of Clinical Trials on March 17, 2019. The registration reference is IRCT20190227042857N1.
引用
- Seifi N, Rezvani R, Sedaghat A, et al. The effects of synbiotic supplementation on enteral feeding tolerance, protein homeostasis, and muscle wasting of critically ill adult patients: a randomized controlled trial. Trials. 2022. PMID: 36195945. doi:10.1186/s13063-022-06668-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。